Functional angiotensin II receptors in cultured vascular smooth muscle cells
- PMID: 6277961
- PMCID: PMC2112084
- DOI: 10.1083/jcb.92.2.289
Functional angiotensin II receptors in cultured vascular smooth muscle cells
Abstract
To study cellular mechanisms influencing vascular reactivity, vascular smooth muscle cells (VSMC) were obtained by enzymatic dissociation of the rat mesenteric artery, a highly reactive, resistance-type blood vessel, and established in primary culture. Cellular binding sites for the vasoconstrictor hormone angiotensin II (AII) were identified and characterized using the radioligand 125I-angiotensin II. Freshly isolated VSMC, and VSMC maintained in primary culture for up to 3 wk, exhibited rapid, saturable, and specific 125I-AII binding similar to that seen with homogenates of the intact rat mesenteric artery. In 7-d primary cultures, Scatchard analysis indicated a single class of high-affinity binding sites with an equilibrium dissociation constant (Kd) of 2.8 +/- 0.2 nM and a total binding capacity of 81.5 +/- 5.0 fmol/mg protein (equivalent to 4.5 x 10(4) sites per cell). Angiotensin analogues and antagonists inhibited 125I-AII binding to cultured VSMC in a potency series similar to that observed for the vascular AII receptor in vivo. Nanomolar concentrations of native AII elicited a rapid, reversible, contractile response, in a variable proportion of cells, that was inhibited by pretreatment with the competitive antagonist Sar1,Ile8-AII. Transmission electron microscopy showed an apparent loss of thick (12-18 nm Diam) myofilaments and increased synthetic activity, but these manifestations of phenotypic modulation were not correlated with loss of 125I-AII binding sites or hormonal responsiveness. Primary cultures of enzymatically dissociated rat mesenteric artery VSMC thus may provide a useful in vitro system to study cellular mechanisms involved in receptor activation-response coupling, receptor regulation, and the maintenance of differentiation in vascular smooth muscle.
Similar articles
-
In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.Br J Pharmacol. 1997 Feb;120(3):488-94. doi: 10.1038/sj.bjp.0700897. Br J Pharmacol. 1997. PMID: 9031754 Free PMC article.
-
Characterization of alpha- and beta-adrenergic and angiotensin receptors in cultured vascular smooth muscle cells of rat aorta.Jpn Circ J. 1985 Sep;49(9):1043-51. doi: 10.1253/jcj.49.1043. Jpn Circ J. 1985. PMID: 2999459
-
Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.Br J Pharmacol. 1994 Aug;112(4):1195-201. doi: 10.1111/j.1476-5381.1994.tb13210.x. Br J Pharmacol. 1994. PMID: 7952881 Free PMC article.
-
The role of angiotensin II receptors in vascular regulation.J Cardiovasc Pharmacol. 1984;6 Suppl 4:S575-86. doi: 10.1097/00005344-198406004-00004. J Cardiovasc Pharmacol. 1984. PMID: 6083400 Review.
-
Receptors for angiotensin: a critical analysis.Can J Physiol Pharmacol. 1979 Feb;57(2):129-39. doi: 10.1139/y79-020. Can J Physiol Pharmacol. 1979. PMID: 232670 Review.
Cited by
-
Large scale preparation of rabbit aortic smooth muscle cells for use in calcium uptake studies.In Vitro Cell Dev Biol. 1986 Jan;22(1):23-7. doi: 10.1007/BF02623437. In Vitro Cell Dev Biol. 1986. PMID: 3944051
-
Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor.Mol Cell Biochem. 2000 Sep;212(1-2):155-69. Mol Cell Biochem. 2000. PMID: 11108147 Review.
-
Liver and Steroid Hormones-Can a Touch of p53 Make a Difference?Front Endocrinol (Lausanne). 2019 Jun 12;10:374. doi: 10.3389/fendo.2019.00374. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31244779 Free PMC article. Review.
-
Different Effects of Lipopolysaccharide on Plasminogen Activator Inhibitor-1 Production in Aortic Media in Vivo and in Culture.J Thromb Thrombolysis. 1996;3(3):215-223. doi: 10.1007/BF00181664. J Thromb Thrombolysis. 1996. PMID: 10613985
-
Transforming growth factor beta up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2.J Biol Chem. 2008 May 30;283(22):15003-14. doi: 10.1074/jbc.M801621200. Epub 2008 Apr 3. J Biol Chem. 2008. PMID: 18387947 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources